JBIO
Jade Biosciences
JBIO
JBIO
41 hedge funds and large institutions have $453M invested in Jade Biosciences in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $454M → $453M (-$1.86M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16.4M | |
| 2 | +$10.1M | |
| 3 | +$4.69M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$2.97M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.64M |
Top Sellers
| 1 | -$3.72M | |
| 2 | -$3.33M | |
| 3 | -$2.39M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$481K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$410K |